These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24047344)

  • 1. Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.
    Compton CL; Schmitz KR; Sauer RT; Sello JK
    ACS Chem Biol; 2013 Dec; 8(12):2669-77. PubMed ID: 24047344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly and proteolytic processing of mycobacterial ClpP1 and ClpP2.
    Benaroudj N; Raynal B; Miot M; Ortiz-Lombardia M
    BMC Biochem; 2011 Dec; 12():61. PubMed ID: 22132756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring.
    Akopian T; Kandror O; Raju RM; Unnikrishnan M; Rubin EJ; Goldberg AL
    EMBO J; 2012 Mar; 31(6):1529-41. PubMed ID: 22286948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity.
    Akopian T; Kandror O; Tsu C; Lai JH; Wu W; Liu Y; Zhao P; Park A; Wolf L; Dick LR; Rubin EJ; Bachovchin W; Goldberg AL
    J Biol Chem; 2015 Apr; 290(17):11008-20. PubMed ID: 25759383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis ClpP proteases are co-transcribed but exhibit different substrate specificities.
    Personne Y; Brown AC; Schuessler DL; Parish T
    PLoS One; 2013; 8(4):e60228. PubMed ID: 23560081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1.
    Leodolter J; Warweg J; Weber-Ban E
    PLoS One; 2015; 10(5):e0125345. PubMed ID: 25933022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.
    Li M; Kandror O; Akopian T; Dharkar P; Wlodawer A; Maurizi MR; Goldberg AL
    J Biol Chem; 2016 Apr; 291(14):7465-76. PubMed ID: 26858247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase.
    Bonnett SA; Ollinger J; Chandrasekera S; Florio S; O'Malley T; Files M; Jee JA; Ahn J; Casey A; Ovechkina Y; Roberts D; Korkegian A; Parish T
    ACS Infect Dis; 2016 Dec; 2(12):893-902. PubMed ID: 27642770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Long-Chain β-Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria.
    Santucci P; Dedaki C; Athanasoulis A; Gallorini L; Munoz A; Canaan S; Cavalier JF; Magrioti V
    ChemMedChem; 2019 Feb; 14(3):349-358. PubMed ID: 30600911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome.
    Moreira W; Santhanakrishnan S; Ngan GJY; Low CB; Sangthongpitag K; Poulsen A; Dymock BW; Dick T
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193668
    [No Abstract]   [Full Text] [Related]  

  • 11. Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease.
    Famulla K; Sass P; Malik I; Akopian T; Kandror O; Alber M; Hinzen B; Ruebsamen-Schaeff H; Kalscheuer R; Goldberg AL; Brötz-Oesterhelt H
    Mol Microbiol; 2016 Jul; 101(2):194-209. PubMed ID: 26919556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of novel pyrrole derivatives as potential ClpP1P2 inhibitor against Mycobacterium tuberculosis.
    Liu P; Yang Y; Ju Y; Tang Y; Sang Z; Chen L; Yang T; An Q; Zhang T; Luo Y
    Bioorg Chem; 2018 Oct; 80():422-432. PubMed ID: 30005200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
    Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the transcriptional repressor LexA: Withstanding drug resistance by inhibiting the bacterial mechanisms of adaptation to antimicrobials.
    Bellio P; Mancini A; Di Pietro L; Cracchiolo S; Franceschini N; Reale S; de Angelis F; Perilli M; Amicosante G; Spyrakis F; Tondi D; Cendron L; Celenza G
    Life Sci; 2020 Jan; 241():117116. PubMed ID: 31790690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase.
    Schmitz KR; Sauer RT
    Mol Microbiol; 2014 Aug; 93(4):617-28. PubMed ID: 24976069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resisting resistant Mycobacterium tuberculosis naturally: mechanistic insights into the inhibition of the parasite's sole signal peptidase Leader peptidase B.
    Dhiman H; Dhanjal JK; Sharma S; Chacko S; Grover S; Grover A
    Biochem Biophys Res Commun; 2013 Apr; 433(4):552-7. PubMed ID: 23510997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An allosteric switch regulates
    Vahidi S; Ripstein ZA; Juravsky JB; Rennella E; Goldberg AL; Mittermaier AK; Rubinstein JL; Kay LE
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5895-5906. PubMed ID: 32123115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP.
    Zeiler E; Korotkov VS; Lorenz-Baath K; Böttcher T; Sieber SA
    Bioorg Med Chem; 2012 Jan; 20(2):583-91. PubMed ID: 21855356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining cross-metathesis and activity-based protein profiling: new β-lactone motifs for targeting serine hydrolases.
    Camara K; Kamat SS; Lasota CC; Cravatt BF; Howell AR
    Bioorg Med Chem Lett; 2015 Jan; 25(2):317-21. PubMed ID: 25541002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the essential ClpP protease in Mycobacterium tuberculosis as a novel drug target.
    Ollinger J; O'Malley T; Kesicki EA; Odingo J; Parish T
    J Bacteriol; 2012 Feb; 194(3):663-8. PubMed ID: 22123255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.